Rotation Bodes Well for More Upside<br />By Rev Shark<br />RealMoney.com Contributor<br />4/25/2008 8:28 AM EDT <br /><br /><br />A person is never happy except at the price of some ignorance. <br />-- Anatole France<br /><br />As I contemplated The Wall Street Journal this morning, I was struck by the generally positive tone. There were several stories discussing how the worst may be over for debt and stocks and a general attitude that things may improve from here. <br /><br />This optimistic tone was further reinforced when I turned on the computer and see that the premarket action is positive even though Microsoft (MSFT) is trading down $1.40. The weakness we saw after hours last night is completely forgotten. <br /><br />Earnings reports have been pretty darn good and oil prices are down a tad, so why shouldn't the market be a bit more upbeat? The economic issues we have been dealing with certainly are no secret, and earnings underscore the argument that maybe the world isn't coming to an end. <br /><br />So the big question we face is whether this market can continue to rally as earnings season winds down and we await the Fed's interest rate decision next week. <br /><br />One potential positive that I have been talking about quite a bit is rotation into some new leadership. Over the last few months, there has been very heavy momentum in certain cyclical, commodity and heavy industry sectors. Oil, steel, base metals, agriculture, oil and solar energy have been very strong, while much of the market has languished. Yesterday we saw a rotation out of those groups and into financials, retail and semiconductors. That is exactly the sort of rotation and/or broadening into new leadership that the market needs to work higher. <br /><br />What we have to do is watch for this rotation theme to develop further. If it doesn't play out, the chances are that the broad market will struggle as well. Good markets need the right sort of leadership, and we can only go so far when oil is going straight up and is driving inflationary pressures. <br /><br />The big danger we face is too much complacency and downright optimism. It is worrisome when there is a choir of voices proclaiming that the worst is over. I don't believe that it is going to be that simple, and I'm looking for another pullback sooner or later. That doesn't mean, though, that the current upside momentum can't continue for a little while. <br /><br />We'd be better served if we had a higher "wall of worry" to climb this morning rather than this cheerful mood following a mediocre report from MSFT, but the bulls have been doing well lately and they are loath to temper their increasing optimism. That bodes well for some sort of pullback in the short term, but if the rotational theme continues, we will have more upside to come. <br />------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: ERIC +17.8%, DECK +12.2%, TRMB +12.0% (also upgraded to Buy from Neutral at Piper Jaffray), ARBA +9.2%, MCRL +8.6%, UHS +7.8%, VISN +7.0%, DV +6.5%, PFWD +6.4% (also upgraded to Outperform at Friedman billings), IBKR +5.8% (also files S-1 relating to offering of 50 mln shares of Class A common stock), SWN +5.7%, YRCW +5.5% (also upgraded to Market Perform at Morgan Keegan), GT +5.3%, DDUP +5.0%, AXP +4.0%, JNPR +3.7%, MEE +2.9%, CRDN +2.9%, AFFX +2.8%, BUCY +2.7%, BIDU +2.2%, CVTX +2.1%, IKAN +1.8%, RVBD +1.5%, NCI +1.2% (upgraded to Buy at Merrill), HUBG +1.1%... Other news: PGNX +26.9% (co and Wyeth announce FDA has approved RELISTOR and announces it approved repurchase program to acquire up to $15 mln of its outstanding common shares; also upgraded to Hold at Citigroup), ABK +8.2% (modestly rebounding after this week's 40%+decline), ALU +6.0% (up in sympathy with ERIC), ETFC +5.0% (still checking for anything specific), V +4.8% (up in sympathy with AXP), TRN +4.8% (Cramer makes positive comments on MadMoney), STM +4.3% (up in sympathy with ERIC), OTTR +3.8% (Cramer makes positive comments on MadMoney), FRE +3.0% (reports monthly volume summary for March; aggregate unpaid principal balance increased to $712.5 bln), GSK +2.6% (still checking), CVA +2.6% (Cramer makes positive comments on MadMoney), BP +1.4% (still checking), HANS +1.4% (announces $200 mln share repurchase program)... Analyst upgrades: THC +6.0% (upgraded to Outperform at Credit Suisse), HMA +5.3% (upgraded to Outperform at Credit Suisse), VM +4.0% (upgraded to Peer Perform at Bear Sterns), CLS +3.5% (upgraded to Sector Outperform at CIBC), SOHU +3.4% (upgraded to Buy at Citigroup), CS +1.6% (upgraded to Neutral at tier 1 firm), NEM +1.2% (upgraded to Sector Perform at CIBC), WMT +1.0% (upgraded to Buy at Merrill).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: ACTG -21.9%, CHE -15.5%, SIRF -14.3%, NTGR -11.6% (also downgraded to Buy at BWS Financial), AMX -11.3% (also downgraded to Neutral at tier 1 firm and downgraded to Hold at Deutsche Bank), SYNA -9.1%, UCBH -8.7% (also downgraded to Market Perform from Outperform at BMO Capital Markets), BJRI -8.0% (also downgraded to Hold at Jefferies), ELGX -7.0%, NTY -6.5%, WPPGY -6.2%, RUTH -5.9%, MSFT -4.7%, WDC -4.3%, GNW -4.3%, CF -4.1%, SHPGY -3.3%, FII -2.9%, MO -2.8% (also hearing removed from Conviction Buy List at tier 1 firm), RACK -2.6% (also plans to name James Wheat chief financial officer), RIO -2.2%, WFR -1.9%, RMBS -1.6%, XXIA -1.4%, EZPW -1.4%... Other news: ISIS -26.8% (FDA provides clarity to Isis regarding the development path for Mipomersen), NSTK -15.1% (a 4.58 mln share common stock offering priced at $1.73), FED -2.9% (reports estimated losses at March 31, 2008), SSL -2.8% (Mazambique raises minimum wage as much as 30%, AIM reports - Bloomberg), SYT -1.9% (still checking)... Analyst downgrades: F -3.1% (downgraded to Neutral at JPMorgan and downgraded to Sell at Merrill and downgraded to Underperform at Bear Sterns), ACI -1.8% (downgraded to Below Average at Caris & Company), DDR -1.1% (downgraded to Sector Perform at RBC).